Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
11
Mins
5th November 2020
The Importance of Molecular Testing in the Treatment of Cholangiocarcinoma
Cholangiocarcinomas (CCA) belong to the constellation of biliary tract cancers (BTC), along with gallbladder carcinomas and ampullary carcinomas…
2
Mins
5th November 2020
PEAR Study: UK Experience of the Management of Pregnancy-Associated brEast cAnceR: A National Retrospective Review of Practice
Breast cancer is the leading cause of death in females aged 35–54 years and 15% of breast cancers first present in females of reproductive age…
8
Mins
5th November 2020
race against time
Breast cancer (BC), which is the most prevalent malignancy in women worldwide, is a heterogeneous disease, in which human epidermal growth…
9
Mins
5th November 2020
Association of Tumour Location and Recurrence in Patients with Non-Muscle Invasive Bladder Cancer
Risk stratification and prognosis estimation is important in patients with non-muscle invasive bladder cancer (NMIBC). NMIBC has a high probability…
1
Mins
5th November 2020
Chemotherapy Options in Recurrent Glioblastoma
Most patients with glioblastoma will develop a recurrence despite initial aggressive therapy with maximum surgical resection and postoperative chemoradiation…
8
Mins
5th November 2020
Phosphate and Oxysterols May Mediate an Inverse Relationship Between Atherosclerosis and Cancer
“If it’s not one thing, it’s another” is the sardonic title of an article by Li et al.1 which describes a puzzling inverse relationship between cancer…
7
Mins
5th November 2020
Nasopharyngeal Rhabdomyosarcoma: A Rare Malignancy Incidentally Found in a Middle-Aged Male with a Diagnostic Dilemma
Rhabdomyosarcoma (RMS) is an infrequent and aggressive malignancy that emerges from embryonic mesenchymal cells…
4th November 2020
Are We Virtually There Yet? Part 1 of 2
This two-part webinar features experts who have been on the leading edge of technology in medicine and share their thoughts on where telemedicine was, where it is now and where it is going.
November 2020
EMJ Neurology 8 [Supplement 1] 2020
Currently, 50 million people are living with Alzheimer’s disease (AD), with estimates suggesting an increase to >150 million by 2050…
11
Mins
3rd November 2020
Empowering Physicians to Advance the Future of Alzheimer’s Disease Management and Care
This series of four talks was aimed at providing healthcare professionals (HCP) with an understanding of the need for early diagnosis of AD to enable refined care
←
1
2
3
…
397
398
399
400
401
402
403
…
897
898
899
→
![EMJ Neurology 8 [Supplement 1] 2020 Feature Image](https://www.emjreviews.com/wp-content/uploads/2020/10/EMJ-Neurology-8-Supplement-1-2020-Feature-Image-940x563.jpg)
